Welcome to our dedicated page for HENRY SCHEIN SEC filings (Ticker: HSIC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Henry Schein, Inc. SEC filings document the formal disclosures of a Nasdaq-listed health care solutions company serving dental and medical practices and alternate care sites. The company’s 8-K filings report operating results, financial condition updates, press-release exhibits, leadership changes, board actions, and executive-compensation matters.
Proxy materials cover annual meeting matters, director and board-governance disclosures, and stockholder voting procedures. The filing record also identifies Henry Schein’s common stock, par value $0.01 per share, traded under HSIC on the Nasdaq Global Select Market, along with related corporate and Inline XBRL cover-page disclosures.
Albertini Andrea reported acquisition or exercise transactions in this Form 4 filing.
Henry Schein Inc. executive Andrea Albertini, CEO, Global Distribution & Technology, received a grant of 60,631 shares of common stock as equity compensation. Following this award, he directly holds 122,092 shares.
The grant consists of restricted stock units under the 2024 Stock Incentive Plan. Half of the grant is performance-based and will vest on the third anniversary of the grant date if specified performance goals are met, with payout for these performance stock units scaling from 0% to a maximum of 200%. The remaining half will vest in equal installments on each of the first four anniversaries of the grant date, in each case subject to continued service.
Henry Schein Inc. director Reed Vaughn Tuckson reported an equity award from the company. On March 6, 2026, he acquired 2,577 shares of common stock at a stated price of $0.00 per share, described as a grant, award, or other acquisition.
The award was granted under Henry Schein’s 2023 Non-Employee Director Stock Incentive Plan. According to the footnote, the restricted stock units generally vest after a 12‑month cliff period, subject to certain exceptions and to his continued service to the company. Following this grant, he directly owned 12,520 shares of common stock.
SHEARES BRADLEY T reported acquisition or exercise transactions in this Form 4 filing.
Henry Schein Inc. director Bradley T. Sheares received an equity award of 2,577 shares of common stock on March 6, 2026. The grant was made at no cash cost to him under the company’s 2023 Non-Employee Director Stock Incentive Plan.
According to the terms, these restricted stock units vest after a 12-month cliff period, contingent on his continued service to Henry Schein. Following this award, he beneficially owns 47,623 shares of the company’s common stock directly.
Henry Schein Inc. director Scott Philip Serota reported an equity award in the company’s common stock. He acquired 2,577 shares on a grant or award basis at $0.00 per share, bringing his directly held stake to 10,790 shares.
The award was granted under Henry Schein’s 2023 Non-Employee Director Stock Incentive Plan. According to the terms, these restricted stock units generally vest after a 12‑month cliff period, conditioned on the passage of time and his continued service to the company.
Separately, an additional 1,000 shares are reported as held indirectly by the Serota Family Trust, for which Mr. Serota and his wife serve as both trustees and beneficiaries.
Margulies Anne H. reported acquisition or exercise transactions in this Form 4 filing.
Henry Schein Inc. director Anne H. Margulies reported an equity award of 2,577 shares of common stock on March 6, 2026. The award was granted at no cash cost to her as a stock-based grant.
The grant was made under Henry Schein’s 2023 Non-Employee Director Stock Incentive Plan as restricted stock units that vest after a 12‑month cliff period, subject to her continued board service. Following this award, her directly held common stock totaled 23,153 shares.
Henry Schein Inc. director Philip A. Laskawy reported an equity award from the company. On March 6, 2026, he acquired 2,577 shares of common stock in the form of restricted stock units at a stated price of $0.00 per share.
The award was granted under Henry Schein’s 2023 Non-Employee Director Stock Incentive Plan. These restricted stock units are scheduled to vest after a 12‑month cliff period, subject to limited exceptions and his continued service to the company. Following this grant, he holds 24,538 shares directly.
Henry Schein Inc. director Kurt P. Kuehn reported an equity award. On March 6, 2026, he acquired 2,577 shares of common stock at a stated price of $0.00 per share through a grant under the company’s 2023 Non-Employee Director Stock Incentive Plan.
According to the award terms, these restricted stock units are subject to 12‑month cliff vesting and require his continued service with Henry Schein during that period. Following this grant, Kuehn’s directly held position increased to 18,264 shares of common stock.
HOMBACH ROBERT J. reported acquisition or exercise transactions in this Form 4 filing.
Henry Schein Inc. director Robert J. Hombach reported an equity award of 2,577 shares of common stock on March 6, 2026. These shares were granted under the company’s 2023 Non-Employee Director Stock Incentive Plan at no purchase price, increasing his directly held stake to 5,421 shares.
According to the award terms, the restricted stock units generally vest after a 12‑month cliff period, provided Mr. Hombach continues to perform services for Henry Schein. This filing reflects routine director compensation in the form of stock-based incentives.
HERRING JOSEPH L reported acquisition or exercise transactions in this Form 4 filing.
Henry Schein Inc. director Joseph L. Herring received an equity award of 2,577 shares of common stock at a stated price of $0.00 per share. The grant was made under the company’s 2023 Non-Employee Director Stock Incentive Plan and is structured as restricted stock units.
These restricted stock units are subject to 12-month cliff vesting and require Mr. Herring’s continued service with the company for vesting to occur, subject to certain exceptions. Following this award, his directly held position increased to 30,325 shares of Henry Schein common stock.